Mulakan
ReutersReuters

Molecular Partners Reports Q3 2025 Financial Results And Clinical Progress, With Dll3-Targeting Radio-Darpin Mp0712 Phase 1 Launch Expected In 2025

RefinitivBacaan kurang dari 1 minit
MOLN

Molecular Partners AG MOLN:

  • MOLECULAR PARTNERS REPORTS Q3 2025 FINANCIAL RESULTS AND CLINICAL PROGRESS, WITH DLL3-TARGETING RADIO-DARPIN MP0712 PHASE 1 LAUNCH EXPECTED IN 2025

EropahReutersSaham Swiss
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Log masuk atau cipta satu akaun percuma selamanya untuk membaca berita ini

Lebih berita dari Reuters